Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases
- 1 January 2007
- journal article
- research article
- Published by Taylor & Francis in British Journal Of Neurosurgery
- Vol. 21 (5) , 496-500
Abstract
Glioblastoma is the most common primary brain tumour. The aim of this study was to determine trends in survival over a 12-year period. Survival data were collected retrospectively for 625 patients who had surgery for histologically-confirmed glioblastoma between 1993 and 2004 in a single centre. Data including age, sex, preoperative Karnofsky performance score, tumour site, date of surgery, and type of surgical and adjuvant treatment were collected. Overall median survival was 189 days; there was no significant change in survival over 12 years. Multivariate analysis identified the following independent positive prognostic factors: age p < 0.0005), Karnofsky score ≥ 70 (p < 0.0001), tumour debulking, rather than biopsy (p < 0.001), right-sided lesion (p < 0.05), unilateral tumour (p < 0.05) and radiotherapy (p < 0.0001). Despite neurosurgical advances, the survival of patients with glioblastoma has not changed for more than a decade. Although, overall, glioblastoma has a short survival, our data show that individual patient survival is heterogeneous.Keywords
This publication has 18 references indexed in Scilit:
- VARIANT OF THE CHEK2GENE AS A PROGNOSTIC MARKER IN GLIOBLASTOMA MULTIFORMENeurosurgery, 2006
- Expression of autocrine motility factor mRNA is a poor prognostic factor in high‐grade astrocytomaPathology International, 2006
- Marital status, treatment, and survival in patients with glioblastoma multiformeCancer, 2005
- Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes ProjectJournal of Neurosurgery, 2003
- Debulking or biopsy of malignant glioma in elderly people – a randomised studyActa Neurochirurgica, 2003
- A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survivalJournal of Neurosurgery, 2001
- Resection, biopsy, and survival in malignant glial neoplasmsJournal of Neurosurgery, 1993
- Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiformeJournal of Neurosurgery, 1993
- Survival after Stereotactic Biopsy of Malignant GliomasNeurosurgery, 1988
- Cerebral HemispherectomyJournal of Neurosurgery, 1949